ストックスクリーナーアプリを入手
385.70
0.63%
-2.46
アフターアワーズ：
385.70
前日終値:
$388.16
開ける：
$388
24時間の取引高:
2.84M
Relative Volume:
1.01
時価総額：
$207.92B
収益：
$36.74B
当期純損益:
$7.71B
株価収益率:
27.10
EPS:
14.2333
ネットキャッシュフロー:
$8.10B
1週間 パフォーマンス:
+1.66%
1か月 パフォーマンス:
+11.90%
6か月 パフォーマンス:
+34.43%
1年 パフォーマンス:
+25.20%
1日の値動き範囲:
$381.89
$391.29
1週間の範囲:
$374.25
$391.29
52週間の値動き範囲:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Compare AMGN vs LLY, JNJ, ABBV, NVS, AZN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
385.70 | 209.24B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
1,017.97 | 992.40B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
248.56 | 598.69B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
234.26 | 410.36B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
166.87 | 321.75B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
203.73 | 323.26B | 58.80B | 10.24B | 8.98B | 3.2788 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-20 | 開始されました | Barclays | Equal Weight |
| 2026-01-20 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-12-05 | アップグレード | Erste Group | Hold → Buy |
| 2025-11-24 | 再開されました | Truist | Hold |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-09-03 | 再開されました | Raymond James | Mkt Perform |
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Amgen Deployed a Record $7.2 Billion in R&D: Here’s What Investors Should Expect - TIKR.com
How Amgen’s $4 Billion Long-Dated Bond Issuance At Amgen (AMGN) Has Changed Its Investment Story - Yahoo Finance
Amgen Recasts Growth Story With Product Momentum And Long Dated Funding - simplywall.st
Amgen Inc. (AMGN): A Bull Case Theory - Insider Monkey
Harvest Portfolios Group Inc. Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Argent Trust Co Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Allianz SE - MarketBeat
A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall - GlobeNewswire Inc.
Insider plans sale of 54,792 AMGN shares (NASDAQ: AMGN) - Stock Titan
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial - TipRanks
Amgen Fine-Tunes Evolocumab: New Bioavailability Study Signals Long-Term Cholesterol Franchise Focus - TipRanks
Amgen Nears a Nivolumab Biosimilar Milestone in Melanoma: What Investors Should Watch - TipRanks
Amgen Inc. $AMGN Shares Purchased by Sumitomo Mitsui Financial Group Inc. - MarketBeat
Handelsbanken Fonder AB Sells 47,932 Shares of Amgen Inc. $AMGN - MarketBeat
Intech Investment Management LLC Has $13.65 Million Position in Amgen Inc. $AMGN - MarketBeat
Erste Asset Management GmbH Decreases Position in Amgen Inc. $AMGN - MarketBeat
Empirical Asset Management LLC Has $306,000 Position in Amgen Inc. $AMGN - MarketBeat
US Bancorp DE Has $194 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat
Primecap Management Co. CA Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
TD Asset Management Inc Has $108.85 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Sets New 52-Week HighHere's What Happened - MarketBeat
Amgen stock hits all-time high at 385.63 USD - Investing.com South Africa
Is Amgen Stock Outperforming the Dow? - Barchart.com
MAI Capital Management Has $21.81 Million Holdings in Amgen Inc. $AMGN - MarketBeat
RWA Wealth Partners LLC Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Evaluating Amgen (AMGN) After Barclays Coverage And Strong Q4 2025 Portfolio Momentum - simplywall.st
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE - Yahoo Finance
Technical Analysis of Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S (NEO:AMGN) - TradingView
Amgen Inc. $AMGN Shares Sold by M. Kulyk & Associates LLC - MarketBeat
Dakota Wealth Management Has $9.15 Million Holdings in Amgen Inc. $AMGN - MarketBeat
EverSource Wealth Advisors LLC Has $5.40 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen’s New UPLIZNA Nod and $4 Billion Bond Sale Might Change The Case For Investing In Amgen (AMGN) - simplywall.st
Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Amgen Inc. (AMGN): Investor Outlook On A Healthcare Giant With A 2.58% Dividend Yield - DirectorsTalk Interviews
Barclays begins Amgen (AMGN) coverage, notes balanced outlook despite trial debate - MSN
Global drugmakers rush to boost US presence as tariff threat looms - Reuters
FY2026 EPS Estimates for Amgen Increased by Erste Group Bank - MarketBeat
Is Amgen (AMGN) Still Attractively Priced After Strong Multi Year Share Price Gains - simplywall.st
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate - Insider Monkey
Lansforsakringar Fondforvaltning AB publ Has $53.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Upgraded at Barclays - Defense World
Smead Capital Management Inc. Cuts Position in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Rating Increased to Hold at Barclays - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Amgen VP Busch sells $375k in AMGN stock - Investing.com
Amgen VP Busch sells $375k in AMGN stock By Investing.com - Investing.com South Africa
The Analyst Verdict: Amgen In The Eyes Of 18 Experts - Benzinga
Here are Friday’s top Wall Street analyst research calls: Amgen, ETSY, Eldorado Gold, GE Aerospace, Merck, Southern Company, Walmart, Yeti, and more - MSN
Barclays Begins Coverage on Amgen (NASDAQ:AMGN) - MarketBeat
Barclays Initiates Coverage on Amgen (AMGN) with Equal-Weight Ra - GuruFocus
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
Amgen Inc (AMGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Busch Matthew C. | VP, Finance & CAO |
Feb 19 '26 |
Sale |
375.79 |
1,000 |
375,790 |
3,423 |
0.73%
1.41%
大文字化:
|
ボリューム (24 時間):